Quantifying Synovial Enhancement of the Pediatric Temporomandibular Joint

J Oral Maxillofac Surg. 2016 Oct;74(10):1937-45. doi: 10.1016/j.joms.2016.03.010. Epub 2016 Mar 21.

Abstract

Purpose: The purposes of this study were to assess a novel method for quantifying temporomandibular joint (TMJ) synovial enhancement on gadolinium-enhanced magnetic resonance imaging (MRI) and to establish normative values to allow early detection of synovitis.

Materials and methods: This is a retrospective cohort study of pediatric patients (aged 0 to 16 years) without jaw pathology who underwent MRI scans with contrast that included the TMJs. From a coronal T1-weighted image, the signal intensity within the superior and inferior joint spaces was divided by the signal intensity of the longus capitis muscle to establish a ratio by age. Intrarater reliability and inter-rater reliability were assessed. A mixed-model regression analysis was used to determine the 95% specificity threshold for normal ratios.

Results: Temporal and optic nerve MRI scans of 158 patients were included. Normative synovial enhancement ratios (95% specificity) thresholds were established: 1.52, 1.68, and 1.55 for superior joint space, inferior joint space, and average of both joint spaces, respectively. Intrarater and inter-rater agreement was excellent.

Conclusions: A ratio of signal intensity of the TMJ synovium to the longus capitis is a reliable method to quantify enhancement controlling for time after contrast infusion and may be useful for diagnosis of TMJ synovitis.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Contrast Media
  • Female
  • Gadolinium DTPA
  • Humans
  • Infant
  • Magnetic Resonance Imaging / methods*
  • Male
  • Optic Nerve / diagnostic imaging
  • Optic Nerve / pathology
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity
  • Synovitis / diagnostic imaging*
  • Synovitis / pathology*
  • Temporomandibular Joint / diagnostic imaging*
  • Temporomandibular Joint / pathology*

Substances

  • Contrast Media
  • gadodiamide
  • Gadolinium DTPA